Transgenic rodent mutation/cancer bioassays: Cell cycle control, cell proliferation and apoptosis as modifiers of outcome

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 398, Issue 1-2, 1998, Pages 189-195

  Roberts, Ruth A ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Apoptosis; Cell cycle; Cell proliferation; Genotoxicity; p53

Indexed keywords

REACTIVE OXYGEN METABOLITE;

APOPTOSIS; BIOASSAY; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; DNA DAMAGE; GENOTOXICITY; MAMMAL CELL; MUTAGEN TESTING; NONHUMAN; PRIORITY JOURNAL; REVIEW; RODENT; TRANSGENIC MOUSE;

MAMMALIA; MUS MUSCULUS; RODENTIA;

EID: 0032574309     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00239-X     Document Type: Article

References (47)

1. Gossen J.A., de Leeuw W.J.F., Tan E.C., Zwarthoff E.C., Berends F., Lohman P.H.M., Knook D.L., Vijg J. Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc. Natl. Acad. Sci. USA. 86:1989;7971-7975.
2. Kohler S.W., Provost G.S., Fieck A., Kretz P.L., Bullock W.O., Sorge J.A., Putman D.L., Short J.M. Spectra of spontaneous and mutagen-induced mutations in the LacI gene in transgenic mice. Proc. Natl. Acad. Sci. USA. 88:1991;7958-7962.
3. Tinwell H., Lefevre P.A., Ashby J. Response of the Muta(TM) Mouse lacZ/galE-transgenic mutation assay to DMN: comparisons with the corresponding Big Blue™ (lacI) responses. Mutation Res. 307:1994;169-173.
4. J. Ashby, H. Tinwell (Eds.), Special Issue: Collaborative Evaluation of Transgenic Mouse Germ Cell Assays, Mutation Res. 388(2/3) (1997).
5. Short J.M. (Ed.) Special issue: transgenic systems in mutagenesis and carcinogenesis. Mutation Res. 307:1994;2.
6. Jacks T. Lessons form the p53 mutant mouse. J. Cancer Res. Clin. Oncol. 122:1996;319-327.
7. Goldsworthy T.L., Recio L., Brown K., Donehower L.A., Mirsalis J.C., Tennant R.W., Purchase I.F. Transgenic animals in toxicology. Fundam. Appl. Toxicol. 22:1994;8-19.
8. French, J.E., Development of an in vivo model of genomic instability (LacI-p53-/-) mice). Crisp Data Base National Institutes of Health, 1996.
9. Ashby J. Identifying potential human carcinogens: the role of genetically altered rodents. Toxicol. Pathol. 25:1997;241-243.
10. Pines J. Arresting developments in cell cycle control. Trends Biochem. Sci. 19:1994;143-145.
11. Sherr C.J. Mammalian G1 cyclins. Cell. 73:1993;1059-1065.
12. Jacks T., Weinberg R.A. Cell-cycle control and its watchman. Nature. 381:1996;643-644.
13. Enoch T., Norbury C. Cellular responses to DNA damage: cell cycle checkpoints, apoptosis and the roles of p53 and ATM. Trends Biochem. Sci. 20:1995;426-431.
14. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
15. Pines J. p21 inhibits cyclin shock. Nature. 369:1994;520-521.
16. Wu H., Wade M., Krall L., Grisham J., Xiong Y., Van Dyke T. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development, and regeneration. Genes Dev. 10:1996;245-260.
17. El-Diery W.S., Harper J.W., O'Connor P.M., Velculescu V.E., Canman C.E., Jackman J., Pietenpol J.A., Hill D.E., Wang Y., Burrell M., Wiman K.G., Mercer W.E., Kastan M.B., Kohn K.W., Elledge S.J., Kinzler K.W., Vogelstein B. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1994;1169-1174.
18. C.O.C. Bellamy, R.D.G. Malcomson, A.H. Wyllie, The roles of p53 in apoptosis and cancer, in: S.J. Martin (Eds.), Apoptosis and Cancer, RG Landes and Company, in press.
19. Lane D.P., Crawford L.V. T-antigen is bound to host protein in SV40-transformed cells. Nature. 278:1979;261-263.
20. Linzer D.I.H., Levine A.J. Characterisation of a 54Kd cellular SV40 tumour antigen present in SV40 transformed cells and uninfected embryonal carcinoma cells. Cell. 17:1979;43-52.
21. Baker S.J., Fearon E.A., Nigro J.M., Hamilton S.R., Preisinger A.C., Jessup J.M., van Tuinen P., Ledbetter D.H., Barker D.F., Nakamura Y., White R., Vogelstein B. Chromosome 17 deletion amd p53 mutations in human colorectal carcinomas. Science. 244:1989;217-221.
22. Hansen R., Oren M. p53 - from inductive signal to cellular effect. Curr. Opin. Genet. Dev. 7:1997;46-51.
23. Lane D.P. p53, Guardian of the genome. Nature. 358:1992;15-16.
24. Jacobson M.D., Weil M., Raff M.C. Programmed cell death in animal development. Cell. 88:1997;347-354.
25. Miyashita T., Reed J.C. Tumor Suppressor p53 Is a Direct Transcriptional Activator of the Human bax Gene. Cell. 80:1995;293-299.
26. Knudson C.M., Korsmeyer S.J. Bcl2 and Bax function independently to regulate cell death. Nat. Gen. 16:1997;358-364.
27. Yin X.M., Oltvai Z.N., Korsmeyer S.J. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature. 369:1994;321-323.
28. Yuan J., Shaham S., Ledoux S., Ellis H.M., Horvitz H.R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1-b-converting enzyme. Cell. 75:1993;641-652.
29. Yang E., Zha J., Jockel J., Boise L., Thompson C.B., Korsmeyer S.J. Bad, a heterdimeric partner for Bcl-Xl and Bcl-2, displaces Bax and promotes cell death. Cell. 80:1995;285-291.
30. Wang L., Miura M., Bergeron L., Zhu H., Yuan J. Ich-1, and ICE/ced-3 related gene, encodes both positive and negative regulators of programmed cell death. Cell. 78:1994;739-750.
31. Thornberry N.A., Rano T.A., Peterson E.P., Rasper D.M., Timkey T., Garcia-Calvo M., Houtzager V.M., Nordstrom P.A., Roy S., Vaillancourt J.P., Chapman K.T., Nicholson D.W. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272:1997;17907-17911.
32. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome C from mitchondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
33. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., Vogelstein B. A model for p53-induced apoptosis. Nature. 389:1997;300-304.
34. Chinnaiyan A.M., Tepper C.G., Seldin M.F., O-Rourke K., Kischkel F.C., Hellbardt S., Krammer P.H., Peter M.E., Dixit V.M. FADD/MORT1 is a comman mediator of CD95(Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271:1996;4961-4965.
35. Longthorne V.L., Williams G.T. Caspase activity is required for commitment to Fas-mediated apoptosis. EMBO J. 16:1997;3805-3812.
36. Jost C.A., Marin M.C., Kaelin W.G. Jr. p73 is a human p53-related protein that can induce apoptosis. Nature. 389:1997;191-194.
37. Richardson F.C., Dyroff M.C., Boucheron J.A., Swenberg J.A. Differential repair of O4-alkylthymidine following exposure to methylating and ethylating hepatocarcinogens. Carcinogenesis. 6:1985;625-629.
38. Midgley C.A., Owens B., Briscoe C.V., Thomas D.B., Lane D.P., Hall P.A. Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J. Cell Sci. 108:1995;1843-1848.
39. Roberts R.A., Hickman J.A., Nebert D.W., Richburg J.H., Goldsworthy T.L. Perturbation of the mitosis/apoptosis balance: a fundamental mechanism in toxicology. Symp. Overview, Fundam. Appl. Toxicol. 38:1997;107-115.
40. Wyllie A.H. Clues in the p53 murder mystery. Nature. 389:1997;237-238.
41. Wood A.C., Elvin P., Hickman J.A. Induction of apoptosis by anti-cancer drugs with disparate modes of action: kinetics of cell death and changes in c-myc expression. Br. J. Cancer. 71:1995;937-941.
42. Collins M.K., Perkins G.R., Lopez-Rivas A. Growth factors as survival signals: regulation of apoptosis. Bioessays. 16:1994;133-138.
43. Canman C.E., Gilmer T.M., Coutts S.B., Kastan M.B. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev. 9:1995;600-611.
44. Fausto N., Webber E.M. Control of liver growth. Crit. Rev. Eukaryot. Gene Expr. 3:1993;117-135.
45. Rolfe M., James N.H., Roberts R.A. Tumour necrosis factor alpha (TNF-alpha) suppreses apoptosis and induces S-phase in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators? Carcinogenesis. 18:1997;2277-2280.
46. R.A. Roberts, Non-genotoxic hepatocarcinogenesis: suppression of apoptosis by peroxisome proliferators, in: J.K. Reddy, T. Suga, G.P. Mannaerts, P.B. Lazarow, S. Subramani (Eds.), Peroxisomes: Biology and Role in Toxicology and Disease, New York Academy of Sciences, New York, 1996, pp. 588-602.
47. Boyle C.C., Hickman J.A. Toxin-induced increase in survival factor receptors: modulation of the threshold for apoptosis. Cancer Res. 57:1997;2404-2409.